About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,732 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,732 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5241-5260 of 28,732 trials

TerminatedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy VolunteersThis study is designed to assess the safety, tolerability, pharmacokinetics and pharmacodynamic effects of an investigational drug (CHK-336) when administered to healthy…NCT05367661·Cincinnati, Ohio CompletedStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisThe purpose of this study is to determine whether Tcelna (imilecleucel-T, autologous T-Cell Immunotherapy) is effective in the treatment of secondary progressive multiple…NCT01684761·Phoenix, Arizona and 35 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedTralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).Primary objective: To evaluate the efficacy of subcutaneous (SC) administration of tralokinumab compared with placebo in treating adolescent subjects (age 12 to \<18 years) with…NCT03526861·Birmingham, Alabama and 86 others

TerminatedA Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress SyndromeTo assess the efficacy of 3 oral dosing regimens of ATI 7505 compared to placebo in patients with PDS by comparing at the end of Day 42 the percentage of patients in each…NCT00630370·Chino, California and 63 others

CompletedA Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy BeforeThe purpose of this study is to determine the number of participants whose cancer shrinks or disappears after treatment on the study.NCT00870870·Anniston, Alabama and 11 others

CompletedTAC Versus TC for Adjuvant Breast CancerThe purpose of this research study is to find out what effects (good and bad) TC or TAC has on early stage HER2- breast cancer.NCT00493870·Birmingham, Alabama and 94 others

TerminatedPost-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMAThe primary objective of the SONOMA Registry is to confirm the safety of the NexStent® Carotid Stent System and FilterWire EZ™ Embolic Protection System in routine clinical…NCT00478673·Huntsville, Alabama and 61 others

TerminatedVinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast CancerRATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.NCT00075673·Cleveland, Ohio

RecruitingA Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft TissueThe purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX…NCT05634369·South Birmingham, Alabama and 21 others

CompletedA Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese SubjectsThe purpose of this study is to determine the effect of nasal PYY3-36 on weight loss post 24 weeks of treatment.NCT00537420·Peoria, Arizona and 28 others

Active not recruitingSafety and Effectiveness of Cochlear Implantation in an Expanded Adult PopulationThis study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved…NCT06293482·Phoenix, Arizona and 8 others

CompletedNational Cardiogenic Shock InitiativeThis study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock.NCT03677180·Birmingham, Alabama and 74 others

CompletedA Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back PainThe primary objective of the study is to determine the analgesic efficacy and safety of ALO-02 extended-release capsules, when compared to placebo, in subjects with moderate to…NCT01571362·Mobile, Alabama and 51 others

CompletedA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightThis is a study of tirzepatide in participants with type 2 diabetes who have obesity or are overweight. The main purpose is to learn more about how tirzepatide affects body weight.NCT04657003·Birmingham, Alabama and 74 others

CompletedDonor Stem Cell Transplant in Treating Patients With Hematologic CancerRATIONALE: Giving chemotherapy and total-body irradiation before a donor peripheral stem cell transplant helps stop the growth of cancer and abnormal cells and helps stop the…NCT00054327·Cleveland, Ohio

CompletedA Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)Open-label, dose-escalation study in subjects with previously treated B-cell malignancies to find maximum tolerated dose (MTD) or pharmacologic active dose of a PI3Kδ inhibitor…NCT02018861·Birmingham, Alabama and 6 others

CompletedDiscontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS StudyThe Main Hypothesis of this extension trial is that among those who have successfully discontinued their DMT as part of the DISCOMS trial (i.e. did not have a new MS relapse or…NCT04754542·Aurora, Colorado and 9 others

CompletedA Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial AllergiesThe purpose of this study is to determine if two allergy medications are more effective than placebo.NCT00712920·Huntington Beach, California and 42 others

RecruitingThis is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCThe goal of this clinical trial is to learn if plecanatide can treat functional constipation in children and adolescents aged 6 to less than 18 years.NCT07723924·Birmingham, Alabama and 28 others

RecruitingRim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary ScrewsThe hypothesis of this study is that the Rim Plate method utilizing interfragmentary screws placed through the plate will result in superior fixation, a lower rate of loss of…NCT06409559·Cincinnati, Ohio

PreviousPage 263 of 1437Next

Heart Diseasein Ohio